BRCA1/2 variant landscape and clinical correlates in high-risk breast cancer patients from Eastern China - Top-Institutions - MDSpire

BRCA1/2 variant landscape and clinical correlates in high-risk breast cancer patients from Eastern China

  • By

  • Wei Gu

  • Najeeb Ullah Khan

  • Huijun Lei

  • Jinzhen Fu

  • Chengyin Xu

  • Xukai Chen

  • Xiao-jia Wang

  • Tianhui Chen

  • June 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Zhejiang Cancer Hospital
    Zhejiang Cancer Hospital

    Hangzhou, Zhejiang

    Key Differentiators

    • Medical Genetics
    • Oncology

  • #2

    Women’s College Research Institute
    Women’s College Research Institute

    Toronto, Ontario

    Key Differentiators

    • Medical Genetics
    • Oncology

  • #3

    University of Toronto
    University of Toronto

    Toronto, Ontario

    Key Differentiators

    • Medical Genetics
    • Oncology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Medical Genetics
    • Oncology

Original Source(s)

BRCA1/2 variant landscape and clinical correlates in high-risk breast cancer patients from Eastern China

  • by Wei Gu, Najeeb Ullah Khan, Huijun Lei, Jinzhen Fu, Chengyin Xu, Xukai Chen, Xiao-jia Wang, Tianhui Chen

  • June 29, 2026

Related Content

Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis

Algebraic evaluation of optimization in tumors classification with numerical assessments via a flask–react web interface

European consensus on pre-operative imaging in breast cancer developed jointly by EUSOBI, ESSO, ESP and ESTRO